Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-124479
Filing Date
2024-11-12
Accepted
2024-11-12 06:10:20
Documents
54
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sprb-20240930.htm   iXBRL 10-Q 1883981
2 EX-31.1 sprb-ex31_1.htm EX-31.1 16686
3 EX-31.2 sprb-ex31_2.htm EX-31.2 15628
4 EX-32.1 sprb-ex32_1.htm EX-32.1 8181
5 EX-32.2 sprb-ex32_2.htm EX-32.2 8294
  Complete submission text file 0000950170-24-124479.txt   5911377

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20240930.xsd EX-101.SCH 881960
56 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20240930_htm.xml XML 607520
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39594 | Film No.: 241442888
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)